As of 3:59pm ET
| -0.195 / -5.39%|
The 5 analysts offering 12-month price forecasts for Correvio Pharma Corp have a median target of 7.00, with a high estimate of 10.50 and a low estimate of 5.75. The median estimate represents a +104.68% increase from the last price of 3.42.
The current consensus among 5 polled investment analysts is to Buy stock in Correvio Pharma Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.